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Abstract 
In this study, we report the development and application of a pseudorabies virus-
based system for delivery of troponeon, a fluorescent Ca2+ sensor to adult canine 
cardiomyocytes. The efficacy of transduction was assessed by calculating the ratio of 
fluorescently labelled and non-labelled cells in cell culture. Interaction of the virus 
vector with electrophysiological properties of cardiomyocytes was evaluated by the 
analysis of transient outward current (Ito), kinetics of the intracellular Ca2+ transients and 
cell shortening. Functionality of transferred troponeon was verified by FRET analysis. 
We demonstrated that the transfer efficiency of troponeon to cultured adult cardiac 
myocytes was virtually 100%. We showed that even after four days neither the 
amplitude nor the kinetics of the Ito current was significantly changed and no major 
shifts occurred in parameters of [Ca2+]i transients. Furthermore, we demonstrated that 
infection of cardiomyocytes with the virus did not affect the morphology, viability and 
physiological attributes of cells. 
 
Keywords: pseudorabies virus, herpes virus, gene transfer, troponeon, cardiomyocytes, 
cell culture, Ito, calcium transient, FRET 
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1. Introduction 
The past decade has witnessed an explosive progress of virus-based gene delivery 
technologies. The reason for this is that, albeit traditional approaches, such as calcium 
phosphate precipitation, electroporation, or liposome-mediated gene transfer perform 
excellently in immortalized cells of various origins, they mostly fail in primary cultured 
cells and under in vivo conditions. Viruses had millions of years to evolve several 
means for effective infection of cells that can be employed by utilizing viruses as 
vectors for delivering exogenous genes to the desired cells. Virus-mediated gene 
transfer methods have also become powerful and widely used experimental tools in 
cardiovascular research. The most important prerequisites for successful in vitro gene 
transfer into adult cardiomyocytes include high quality of primary cell culture and an 
effective transfer vector with limited cytotoxicity and other side effects. However, adult 
cardiomyocytes are difficult to transduce using methods that work well in other systems 
because cardiac cells do not divide, have a relatively short lifetime in culture and are 
highly sensitive to toxic effects. Gene transfer methods used in cardiovascular research 
can be divided into two groups: physicochemical and viral vector-based systems. Non-
viral methods involve cationic liposome/plasmid DNA complexes, incubation with 
naked DNA, and calcium phosphate precipitation [1, 2]. All of these methods suffer 
from severe limitations such as cytotoxicity, very low transfection efficiency especially 
in vivo applications, and short-term expression of transduced genes due to intracellular 
degradation of foreign DNA. The above limitations urged the application of more 
efficient virus vector-based approaches for gene delivery to the cardiovascular system. 
The following viral systems have been applied in molecular cardiology: adenovirus 
vectors (Ads), adeno-associated viruses (AAVs), retroviruses (RV) like lentivirus (HIV-
1) and herpes simplex virus (HSV-1)-derived vectors [1, 2]. Currently, Ads and AAVs 
 3
are the most frequently used tools for delivering genes into the cells of the 
cardiovascular system, both in vivo  and in vitro [3, 4]. While Ads–based vectors allow 
relatively highly efficient delivery of transgenes to cardiac cells, this system provides 
only transient expression of transferred genes since the virus does not integrate into the 
host genome [5]. The application of Ads have further limitations including strong 
immune responses by the host organism, limited space for transgene integration and 
during adaptation may have moderately difficult quality control. An additional problem 
with Ads systems is related to the infection efficiency. The coxsackie adenovirus 
receptor (CAR) is a key determinant for the attachment and cellular uptake of 
adenoviruses [6]. However, CAR expression is maximal in neonates and gets reduced 
rapidly after birth in several organs such as heart, muscle and brain resulting in lower 
penetration rate of adenovirus vectors [7]. 
Recombinant AAV vectors are able to effectively transduce foreign genes to a 
variety of cell types including both dividing and post-mitotic cells in both in vitro and in 
vivo experimental systems [8]. The AAV-based systems have a number of favourable 
attributes, such as lack of parental agent pathogenicity and vector-related cytotoxicity, 
minimal immunogenicity, and the capacity for stable long-term transgene expression. 
The main disadvantages of AVV vector–based approaches include the difficulty of 
producing high-titer virus stocks of consistent purity and bioactivity, and the limited 
packaging capacity of a maximum 4.8 kb insert-size [9]. Lentivirus-based gene transfer 
has been reported in a wide variety of cell types, including cardiomyocytes [10]. 
Current lentiviral vectors are capable of transducing mitotically quiescent cells, 
particularly within the cardiovascular system. The strengths of this system include the 
ability of long-term stable transgene expression, an increased packaging capacity 
compared with AAV, and the other commonly used integrating vector [11]. The 
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disadvantages of lentivirus-based gene delivery systems are the relative low level of 
transgene expression and the limited transgene carrying capacity of the virus. 
Pseudorabies virus (PRV), a causative agent of Aujeszky’s disease of swine, is an 
alpha-herpesvirus belonging to family of Herpesviridae. Several previous reports have 
been successful in construction of PRVs for delivering foreign genes to neurons [12]. 
PRV is especially an important tool for labelling neural circuits [13], which was 
combined with delivery of activity markers to labelled neurons [14]. 
In this study, we have developed a method for short-term culture of isolated 
myocytes that retains their morphological as well as physiological integrity and a 
pseudorabies virus (PRV)-based system for delivery of foreign genes to adult cardiac 
muscle cells. Troponeon (TN-L15) [15], a FRET-based activity marker was selected as 
a model transgene system. Troponeon is a genetically-encoded fluorescent Ca2+ sensor 
that is suitable for the imaging of cellular activity in neurons, muscle and cardiac cells. 
Pseudorabies virus was modified to disable to replicate on post-mitotic cells but 
retaining its capacity for high titer multiplication on dividing cultured epithelial cells. 
The strengths of the presented system is a very high gene transfer efficiency, low toxic 
effect, the capacity for relative long-term transgene expression, and the delivery of large 
or multiple transgenes. The suitability of PRV-based gene delivery technique was 
evaluated in several ways. We performed simultaneous measurements in non-infected 
control and infected myocytes following isolation and infection. Retained functionality 
of the sarcolemmal ion channels was tested by measuring a characteristic multichannel 
current Ito. Intactness of the excitation contraction coupling (ECC) machinery and 
contractile function was demonstrated by monitoring intracellular calcium transients 
and cell shortening. Finally, undisturbed functioning of the transmitted gene was 
verified by FRET monitoring of the calcium transient currents. 
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2. Materials and Methods 
2.1 Cells and viruses 
The wild type Kaplan strain [16] of pseudorabies virus (PRV) was used as parent strain 
for the generation of recombinant viruses used in this study. Viruses were propagated 
on subconfluent monolayer of porcine kidney (PK-15) cells. Cells were grown in 
DMEM supplemented with 5% fetal calf serum at 37°C with 5% CO2. The stocks of 
PRV were prepared as follows: PK-15 cells were infected with PRV at a multiplicity of 
1 p.f.u/cell, harvested after 24h, followed by freezing and thawing three times. The cells 
were then centrifuged and the pellet discarded. The supernatant fluid was stored in 400 
μl aliquots at -80°C. 
2.2 Reporter genes 
Tn-15 (troponeon), a FRET-based fluorescent calcium sensor [15], was used as an 
activity marker in our experiments. The troponeon gene was placed under the control of 
the major immediate early promoter of human cytomegalovirus (pCMV), which 
provided a high level of gene expression. The marker gene expression cassette also 
contained simian virus 40 (SV40)-derived sequences including polyadenylation signal 
and transcription termination sequences. In addition, a lacZ gene equipped with the 
above regulatory sequences was also used as a reporter gene for the identification of 
mutant viruses. 
2.3 Construction of targeting vectors 
In our system, a typical targeting plasmid contains a marker gene expression cassette 
flanked by subcloned viral DNA sequences, which serves as homologous DNA regions 
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for the insertion of marker genes via homologous recombination. The DNA sequences 
used for mutagenesis and as insertion sites for reporter genes are listed on Figure 1. 
Ribonucleotide reductase (RR) gene The details of the construction of RR gene 
targeting vector was described elsewhere [17]. Briefly, a 5-kbp SalI-F fragment of PRV 
DNA containing both subunits of RR gene was isolated and cloned to pRL494, a 
palindrome-containing positive selection vector [18]. This plasmid was cut with ScaI 
and MluI restriction endonucleases generating a 1,805-bp deletion, which included a 
1,789-bp DNA fragment from the 3' end of large (RR1) and a 7-bp DNA sequence from 
the 5' end of small subunit (RR2) of ribonucleotide reductase gene. Subsequently, free 
DNA ends were filled up by Klenow enzyme followed by attaching an EcoRI linker to 
the blunt DNA ends. As a final step, a lacZ gene expression cassette bracketed by 
EcoRI sites was subcloned to the EcoRI site of this plasmid. 
Early protein 0 (EP0) gene Generation of EP0 gene targeting vector was described 
previously [19]. Briefly, the 9.4-kb KpnI-F DNA fragment containing the EP0 gene was 
subcloned into pRL425; followed by cleaving with BamHI restriction endonuclease, 
which resulted in the deletion of a 1390-bp sequence, including almost the entire EP0 
gene. Free DNA ends were converted to EcoRI sites via linker insertion and then 
religated. The same lacZ gene expression cassette as above was subcloned to the EcoRI 
site of this plasmid. 
Putative antisense promoter (ASP) region The 4.9-kb BamHI-8’ PRV DNA fragment 
was isolated and subcloned to pRL525 cloning vector [18, 20]. The DraI site located in 
the putative TATAA box of ASP was used for the insertion of EcoRI thereby destroying 
its potential function. The fluorescent marker gene expression cassettes (GFP, 
troponeon) were inserted to the EcoRI site of this plasmid. 
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2.4 Generation and isolation of recombinant viruses 
Recombinant viruses were generated by means of homologous recombination between 
parent PRV genomes and targeting plasmids containing reporter genes bracketed by 
virus sequences. Viral DNA was transfected to actively growing PK-15 cells along with 
the appropriate targeting plasmid using lipid-mediated gene delivery (Lipofectamine 
2000 Reagent, Invitrogen). Viral DNA for the transfection was prepared from virions 
purified from the medium of infected cells showing total cytopathic effects by isopycnic 
centrifugation on a discontinuous gradient, as described previously [12]. The lacZ gene-
expressing viruses were screened based on their blue plaque appearance in the presence 
of 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-Gal), the chromogenic 
substrate of β-galactosidase. Blue plaques were picked and plaque purified to complete 
homogeneity. Plaques formed by recombinant viruses carrying the fluorescent markers 
were detected visually on the basis of their fluorescence. Recombinant viruses were 
isolated by 6-15 cycles of plaque purification procedure using a fluorescence 
microscope (Olympus IX-71). 
2.5 Isolation of adult canine cardiomyocytes  
All experiments were conducted in compliance with the Guide for the Care and Use of 
Laboratory Animals (USA NIH publication No 85-23, revised 1985). The protocols 
were approved by the review board of the Committee on Animal Research (CAR) of the 
Albert Szent-Györgyi Medical University. The modified protocol for cell isolation was 
based on established procedures described earlier in detail [21]. 
Canine ventricular myocytes were enzymatically dissociated as follows. A portion of 
the left ventricular wall containing an arterial branch large enough to cannulate was 
perfused in a modified Langendorff apparatus with solutions in the following sequence: 
1) normal Tyrode's solution (10 min), 2) Ca2+-free Tyrode solution (10 min), and 3) 
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Ca2+-free Tyrode solution containing collagenase (type I, 0.66 mg/ml) and bovine serum 
albumin (fraction V, fatty acid free, 2 mg/ml) (15 min). Protease (type XIV, 0.12 
mg/ml) was added to the final perfusate while and another 15 - 30 min of digestion was 
allowed. Cells were stored in KB solution. The composition of solutions were (in mM): 
a) normal Tyrode's solution - NaCl 135, KCl 4.7, KH2PO4 1.2, MgSO4 1.2, HEPES 10, 
NaHCO3 4.4, glucose 10, and CaCl2 1.0 (pH 7.2 adjusted with NaOH); b) Ca2+-free 
Tyrode solution - NaCl 135, KCl 4.7, KH2PO4 1.2, MgSO4 1.2, HEPES 10, NaHCO3 
4.4, Glucose 10, and taurine 20 (pH 7.2 adjusted with NaOH); c) KB solution - KOH 90, 
L-glutamic acid 70, taurine 15, KCl 30, KH2PO4 10, MgCl2 0.5, HEPES 10, glucose 11, 
and EGTA 0.5 (pH 7.3 adjusted with KOH). All chemicals used in this method were 
purchased from Sigma Chemical Co. 
2.6 Culture and infection of myocytes 
The entire culture procedure was performed in a class II flow hood. The freshly isolated 
myocytes were centrifuged five times for 1 min at 50 g in sterile 10% PBS. The 
supernatant was replaced first by 500 μM then by 1 mM Ca2+ containing PBS solution. 
The mild centrifugation steps removed the majority of bacterial cells, most non-
myocytes and non-functioning myocytes. Precipitated cells were resuspended in culture 
medium and plated on laminin coated (1 µg/cm2) sterile cover glass at densities of up to 
103 rod-shaped cells cm−2. Cells were left 4 hours to attach to the plate and after this 
time period non attached cells were removed. Following the first medium change, 
subsequent medium changes were carried out every day. Culture medium consisted of 
serum-free medium 199 (M199) supplemented with 25 mM NaHCO3, 5 mM ceratine, 2 
mM L-carnitine, 5 mM taurine, 100 units/ml insulin (CCTI supplemented medium) and 
50μg/ml gentamycin. All chemicals used in this procedure were purchased from Sigma. 
Cells were maintained at 37°C under sterile conditions in an incubator ventilated with 
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5% CO2 and 95% air. After 4 hours, plate attached cells were infected. Freshly isolated 
canine cardiomyocytes were first washed with PBS, followed by low-speed 
centrifugation and resuspension in culture medium. Subsequently, after a 4-hour 
incubation at 37C° in a CO2 incubator, cells were infected with various titers of 
recombinant viruses for 12 hours then washed and the culture medium was changed. 
Infected cells were used for analysis at various time points. 
2.7 Evaluation of infection efficacy and morphological changes in cultured 
cardiomyocytes 
Cell shape and morphology are closely linked with some aspects of cell function such as 
excitation–contraction coupling. Therefore, monitoring these properties may give 
indications of physiological changes that are occurring. Morphological changes of cells 
were observed by light microscope on a daily basis parallel with physiological 
measurements. Troponeon-positive cells were examined by fluorescence microscopy 
from one to three days following isolation at standard titer of viruses. Infection efficacy 
was determined separately for infected cells by manual cell counting using a fluorescent 
microscope (Olympus IX-71). 
2.8 Evaluation of the physiological state of the virus infected cells 
2.8.1. Evaluation of the electrophysiological state of the cells by Ito analysis  
Ito currents were measured at 37 ºC using the whole-cell configuration of the patch-
clamp technique. Measurements were performed daily starting with day 0, when only 
freshly isolated non-infected myocytes were investigated. In the following days control 
and infected cells were studied separately by placing cover glasses with the attached 
cells in the recording chamber mounted on the stage of an inverted microscope 
equipped with epifluorescence assembly (Olympus IX50, Tokyo, Japan). Only rod-
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shaped cells with clear cross striations and relatively strong GFP signal were used. 
HEPES-buffered Tyrode's solution containing (in mM): NaCl 144, NaH2PO4 0.33, KCl 
4.0, CaCl2 1.8, MgCl2 0.53, glucose 5.5 and HEPES 5.0 at pH of 7.4 (by NaOH) served 
as normal superfusate. Cell capacitance (199.3±13.7 pF, n=69) was determined by 
applying a 10 mV hyperpolarizing pulse from a holding potential of -10 mV. Cell 
capacity was calculated as the integral of the capacitive transient divided by the 
amplitude of the voltage step. Patch-clamp micropipettes were fabricated from 
borosilicate glass capillaries (Clark, Reading, UK) using a P-97 Flaming/Brown 
micropipette puller (Sutter Co, Novato, CA, USA). These electrodes had resistances 
between 1.5 and 2.5 Mohms when filled with pipette solution containing (in mM): K-
aspartate 100, KCl 45, K2ATP 3, MgCl2 1, EGTA 10 and HEPES 5. The pH of this 
solution was adjusted to 7.2 by KOH. Nisoldipine (1 µM) (obtained as a gift from the 
Bayer AG, Leverkusen, Germany) was used in the external solution to eliminate inward 
Ca2+ current (ICa). Membrane currents were recorded with Axopatch-200B patch-clamp 
amplifiers (Axon Instruments, Foster City, CA, USA). After establishing a high (1-10 
Gohm) resistance seal by gentle suction, the cell membrane beneath the tip of the 
electrode was disrupted by suction or by application of 1.5 V electrical pulses for 1 - 5 
ms. The series resistance was typically 4 - 8 Mohm before compensation (50 - 80%, 
depending on the voltage protocols). Experiments where the series resistance was high, 
or substantially increased during measurement, were discarded. Membrane currents 
were digitized using a 333 kHz analogue-to-digital converter (Digidata 1200, Axon 
Instruments) under software control (pClamp 8.0, Axon Instruments). Analyses were 
performed using pClamp 8.0 (Axon Instruments) software after low-pass filtering at 1 
kHz. All patch-clamp data were collected at 37 °C. 
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2.8.2. Evaluation of cell function by monitoring [Ca2+]i transient and cell 
shortening 
24-72 hours following viral infection cultured myocytes were loaded by incubation for 
20 min with the acetoxymethyl ester (AM) form of a single wavelength calcium-
sensitive fluorescent dye (Fluo-4, Molecular Probes Inc. 1–2µM from a stock of 1mM 
in DMSO + 20% pluronic acid) at room temperature. The technique for calcium 
transient detection was based on established procedures described earlier [22]. After this 
incubation period the cover glass with attached cultured myocytes was mounted in a 
low volume imaging chamber (RC47FSLP, Warner Instruments, USA) and placed on 
the stage of an inverted fluorescent microscope (IX71, Olympus, Japan). The cells were 
superfused with normal Tyrode solution at 37ºC (1ml/min). Myocytes were stimulated 
at a constant frequency of 1 Hz through a pair of platinum electrodes by an electronic 
stimulator. The dye was excited at 480 nm, fluorescence emission was recorded at 535 
nm (Chroma, USA). Optical signals were recorded by a photon counting 
photomultiplier module (H7828, Hamamatsu, Japan), and sampled at 1 kHz. 
Measurements were performed and data were analyzed using the Isosys software 
(Experimetria Ltd, Hungary). Cell shortening from both ends was determined by a 
video edge detection system (VED-105, Crescent Electronics, Sandy, Utah, USA). All 
experiments were performed at 37 °C, using an automatic temperature controller (TC-
344B, Warner Instruments, USA). 
2.8.3. Evaluation of the functionality of the transferred gene by FRET 
measurement 
For testing the functionality of the transferred gene, following the incubation period the 
cover glass with the attached primary cultured cardiomyocytes was mounted in a low 
volume imaging chamber (RC47FSLP, Warner Instruments, USA) on the stage of an 
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Olympus IX71 inverted microscope outfitted with a 75 W Xe arc lamp for epi- and a 
100 W tungsten-halogen lamp for transillumination.. The myocytes in the chamber were 
superfused with normal Tyrode solution (1ml/min) and stimulated at a constant 
frequency of 1 Hz by an electronic stimulator (Experimetria) through a pair of platinum 
electrodes. All measurements were performed at 37 °C, by using an automatic 
temperature controller (TC-344B, Warner Instruments, USA). The optical signals were 
typically monitored 20-36h after infection in selected myocytes expressing the 
genetically encoded FRET-based sensor troponeon (csTnC-L15). Cells with medium-
high level of fluorescence were selected for measurement. Though often troponeon 
fluorescence is already visible 16h following infection, optical signals were found to be 
optimal for recording after 24h. 
Fluorescent optical signals were monitored by a dual channel photon counting 
system. An Olympus filter cube containing a CFP excitation filter (436/20x) and a CFP 
dichroic mirror  (455DCLP) but no emission filter, was inserted into the light path of 
the microscope. A connector box for dual emission fluorescence with two 
interchangeable dichroic mirror holders and three detector ports (P226/0II/011, Cairn 
Research Ltd, UK) equipped with two photon counting photomultiplier modules 
(H7828, Hamamatsu, Japan) was attached to the left side port of the microscope. The 
fluorescent signal from the microscope was splitted by a YFP dichroic mirror (515LP). 
A second dichroic mirror (565DCLP) was used to separate the longer wavelength 
(FRET) fluorescence from the red filtered (> 580 nm) transillumination light used for 
visual observation of the cell by a video camera mounted on the 3rd, back port of the 
connector box. The splitted fluorescence components were band pass filtered (480/30m 
and 535/30m for CFP and citrine, respectively), integrated with 1 ms time resolution by 
two photon to voltage converter units (Ionoptics, US) and collected for data processing. 
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All interference filters and dichroic mirrors used are avaiable in filter sets 31036V2 and 
41028 from Chroma Technology Corporation (US). 
Changes in [Ca2+]i levels were characterized by the ratio of the emitted fluorescence 
intensities obtained at 480 and 535 nm wavelengths, (FFRET_CITRINE 535/ FCFP 480) 
following optical signal correction steps for photobleaching and non-specific 
background fluorescence. Photobleaching leads to a steady decrease in the FRET ratio 
over time, because citrine is less photostable than CFP. To correct for bleaching, we 
multiplied the intensity of the CITRINE channel by a correction factor calculated from 
the intensity shift between two time points. For background correction we subtracted 
from the optical signals the nonspecific background fluorescence determined at both 
wavelengths by moving off the cell from the light path: FRATIO_corr = (F–F0)CITRINE / (F–
F0)CFP. The background-corrected fluorescence ratio versus time curve can be 
considered as a representation of the intracellular Ca2+ transients (Fig 7). 
2.9 Data analysis 
All patch-clamp results and optical measurements were compared using Student's t-tests 
for paired and unpaired data and expressed as mean ± SEM values. Statistical 
significance of differences obtained between control and virus infected preparations was 
evaluated with Student’s t-test for paired or unpaired data, as relevant. Differences were 
considered significant when p<0.05. 
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3. Results 
3.1 Morphological changes of cultured cardiomyocytes 
Using the described method for isolation of adult dog left ventricular myocytes, we 
routinely obtained a high yield (more than 80%) and high (more than 80%) percentage 
of rod-shaped myocytes that were suitable not only for acute functional studies but, 
more importantly, for short-term culture and gene transfer. Figure 2A shows a trans-
illumination image of freshly isolated and 1-day-old cultured cardiomyocytes from the 
left ventricle. To establish optimal surviving conditions several culture conditions were 
tested based on microscopic evaluation of changes in cellular morphology during the 
four days of culture. Cultured cells were used 1-3 days after isolation. During this 
period, visible small-scale changes in cell shape and cross-striation could be observed. 
Figure 2B shows representative photographs of canine myocytes over time in culture. 
Features typical of acutely isolated (Day 0) cells were the rod shape with rectangular 
stepped ends and clear cross-striations. After 1 day (Day 1) in culture, the cells were 
still rod-shaped with clear cross-striations; however, the ends of the cells started to 
become slightly rounded in appearance. After 3 days (Day 3) in culture, cells remained 
rod-shaped and cross-striated, and the main change was that cell ends became 
progressively more rounded (see Table 1 for cell survivals). 
3.2 Efficacy of virus infection in cultured cardiomyocytes 
Survival rates were found to be dependent on the isolation procedure, density of the 
attached myocytes and the applied virus titer. Intriguingly, a higher total number of 
viable cells were observed on the laminin-coated surfaces after plating in CCTI 
supplemented medium. As respective panels of Fig 2 and 3 (upper panel) show, even 
after three days, the cell culture contained a substantial number of good quality cells 
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both in the control and virus infected groups. Surprisingly, a moderately but 
consistently higher cell survival rate was found in virus infected groups as compared to 
non-infected groups (not shown). The infection efficiency was found to be 100%, that is 
24h post-infection every surviving cells emitted fluorescent signals provided that high 
dose of virus was used for the infection (Fig 3 bottom panel). 
3.3 Whole-cell patch-clamp recordings 
The whole-cell configuration of the patch-clamp technique was used to record the 
transient outward Ito current. Ito was chosen as a physiological assay because it is a large 
current that can be measured relatively easily in isolated canine ventricular myocytes. 
The current was activated by 300 ms long depolarizing voltage pulses from the holding 
potential of -90 mV to test potentials ranging from 0 to +60 mV with a pulse frequency 
of 0.33 Hz. The amplitude of Ito was measured as the difference between the peak and 
the sustained current at the end of the voltage pulse. Figures 4A shows typical 
recordings of Ito measured after one (Day 1) and three days (Day 3) of culture either in 
control (top panels) or virus infected cells (bottom). Figure 4B summarizes all Ito 
measurements performed after 0-4 days of culture in both groups. As the corresponding 
panels of Figure 4 show, the amplitude of the Ito was reduced by less than 10% in virus 
infected myocytes (VM) compared to control non-infected cells (CM) even after 4 
elapsed days. Moreover current amplitude was somewhat larger in PRV-infected cells 
compared to that of observed in control cells. Mean Ito density (Fig. 4B) was similar for 
CM and VM cells after 1 day. The Ito current density in VM changed in four days from 
19.6 ±1.4 to 24.6±2.6 pA/pF (n=10-12), which corresponds well with that observed in 
CM (from 19.3±2.1 to 17.1±1.5 pA/pF, n=8-10). Although mean Ito density of several-
day-old (2, 3, 4) cultured myocytes was significantly larger in VM than CM. The Ito 
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kinetics (activation and inactivation properties) was also not significantly altered by the 
virus infection. 
3.4 Parameters of intracellular Ca2+ transients and contractility 
Cultured myocytes were stimulated at a constant frequency of 1 Hz through a pair of 
platinum electrodes. Similarly to Ito measurements, the steady-state [Ca2+]i transient and 
contractile function were measured and compared on a daily basis both in the infected 
and control cell populations. Original recordings of [Ca2+]i transients and cell shortening 
before and after virus infection are presented in Figure 5. The calcium transient kinetics 
were significantly distorted in culture, but were also not significantly altered by the 
virus infection. As Figure 6 summarizes, we found no statistically significant 
differences in either the amplitude of calcium transient (A) or diastolic calcium level 
(B) between the studied groups. Moreover, transient decay time (C) in non-infected 
control myocytes was significantly larger than in the virus infected group after two and 
three days in culture. Conversely in virus-infected group’s decay time was similar to 
freshly isolated cells. These results suggest that the normal control cell population may 
be lost their some calcium removal mechanism. The cell-shortening measurements (D) 
represent a significant decline in non-infected cell culture after 1 and 3 days. Data 
indicate no significant changes in these parameters. 
3.5 Functionality of FRET-based calcium sensor 
Freshly isolated ventricular myocytes were infected with the virus following 4h plating 
and fluorescence could already be detected within 16h. The functionality of the 
transferred gene was verified by monitoring [Ca2+]i. Figure 7 shows two typical 
fluorescence signal emissions measured in troponenon-expressed cells obtained at 485 
nm and 535 nm excitation (upper panel). The lower panel shows the ratio of the citrine 
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and CFP emitted signals representing the changes of the [Ca2+]i levels in the studied 
cells. This measurement clearly shows that virally-encoded troponenon retained its 
ability of indicating [Ca2+]i levels in cardiomyocytes. 
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4. Discussion 
Recent advances of transgenesis and gene targeting technologies have heralded a 
new era of cellular physiology to study molecular function using genetically engineered 
animal models and genetically encoding vector-based gene transfer systems. Practically, 
the mouse is the only mammalian species in which transgenic technology efficiently 
works. Several transgenic and gene-targeted models have been generated for the over-
expression [23, 24], and genetic ablation of key proteins [25, 26] governing cardiac 
structure and function. 
However, the mouse is not an ideal species for modelling human disease like heart 
failure, myocardial infarction and arrhythmia studies, because the mouse heart has 
distinctly different action potential waveform due to its different underlying ionic 
current structure [27, 28]. Transducing foreign genes to cardiac cells of living animals is 
a feasible technique in several animal models; however, performing 
electrophysiological measurements in vivo is not easy therefore in vitro 
electrophysiological techniques are usually used in cultured cells for this purpose. 
Similar experiments were performed in a recently published work using cultured human 
atrial myocytes [29] and myocytes isolated from rat, a species from which producing 
long term cell culture is much easier.  
Gene transfer to cardiac myocytes has been traditionally carried out in neonatal 
cells. However, these cells undergo differentiation, and as a result, this model is 
inappropriate for certain experiments since differentiating cells have different currents 
than that of from adult cells. Therefore, in vitro transducing of isolated cardiac 
myocytes can be a useful alternative for investigations of cardiovascular cell physiology 
and diseases. 
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The structural changes during culturing ventricular myocytes were studied and as 
well [30, 31]. These changes are associated with culturing procedures associated effects, 
which may change a number of physiological properties of cells in culture. Therefore, 
some possible alterations in the Ca2+ handling and sarcolemmal ionic currents may have 
been diminished in cultured cells. 
Another potential application of our viral gene transfer strategy is to introduce 
siRNA for silencing pore or auxiliary ionic channel subunits underlying transmembrane 
ionic currents. In this study we opted for canine model, since the dog unlike the mouse 
and rat is known to have action potential and ionic current characteristics similar to 
human [32]. We have chosen the transient outward current for testing the possible 
effects of viral infection because Ito is a relatively large current and present in all cells. 
Also it can be relatively easily measured. The Ito gene structure is rather complex. The 
Ito current in canine myocytes resembles human myocytes and has a large conducting 
pore forming unit Kv4.3 connected with several auxiliary subunits such as KChIP2, 
KCNE2 and DPPX [33]. In the present work, we measured the effect of the viral 
infection on Ito and we found that the virus did not affect either the density or kinetics of 
Ito current (Fig 4). 
Since their introduction more than twenty years ago of Ca2+-sensitive fluorescent 
dyes have been used to evaluate intracellular free calcium concentration ([Ca2+]i) [34], 
enabling investigators to gain unprecedented insights into the mechanisms of cell 
signalling. The dynamics of changing Ca2+ concentrations at cellular level and well-
defined subcellular spaces in excitable cells, during the course of membrane 
depolarization can now be understood in the context of disease processes such as 
cardiac arrhythmias and heart failure. Although many details of excitation-contraction 
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coupling were described previously, novel quantitative fluorescence techniques have 
significantly improved our understanding of major cell regulatory pathways. 
Fluorescent dyes commonly used for Ca2+ imaging are based on bis(2-
aminophenoxy)ethane tetraacetic acid (BAPTA) structure and subsequently on bis(2-
aminoethyl ether) tetraacetic acid (EGTA) backbone conjugated to a fluorescent moiety. 
Fura-2, indo-1 and fluo-4 are the most widely used fluorescent dyes for monitoring 
intracellular [Ca2+]; in their acetoxymethyl ester form they can relatively easily be 
loaded into cells, are relatively photostable and are well suited for reliable detection of 
changes in Ca2+ concentration under physiological conditions [35]. These Ca2+ 
indicators with low molecular weight have some important advantages as great dynamic 
range, increased sensitivity, high fluorescent intensity and rapid response kinetics, but 
also have some limitations, being not targetable and subcellular localization of dye can 
not be controlled [36]. Recently developed genetically encoded Ca2+ indicators (GECIs) 
are defined as optical Ca2+ sensors produced by the expression of specific genes. These 
proteins contain a light-emitting fluorescent protein unit and a Ca2+-responsive unit. 
Troponeon, a typical member of the GECI family is composed of a calcium-binding 
domain carrying a variant of troponin C protein and a pair of mutant green fluorescent 
proteins (CFP and Citrine) engineered for fluorescence resonance energy transfer 
(FRET) [15]. A significant difficulty in using these new Ca2+ sensors is their low 
efficiency of transfection into several cell types, cardiomyocytes included. On the other 
hand, the strengths of GECIs include the following: localization can be controlled by a 
custom signal sequence; it can be genetically fused to a protein of interest. GECIs can 
be maintained within cells over days to weeks and expression level/concentration of 
GECIs can be well controlled by incorporating a promoter [37]. 
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At present, in spite of permanent improvements, techniques for introducing 
foreign genes to cultured adult cardiomyocytes suffer from substantial limitations, such 
as relatively low infection efficacy and/or cell surviving rate for the integration of 
transgenes be delivered [38, 39]. In addition, a number of studies demonstrated that 
vector associated cytotoxic effects directly affect a number of (electro) physiological 
properties of the cells [1].  
In this study, we demonstrated that pseudorabies virus vectors can effectively 
penetrate cultured dog cardiomyocytes and that the transferred foreign gene (troponeon) 
could be detected already at 16 hours following infection and until at least four days 
post-infection. Furthermore, we showed that infected cardiomyocytes tolerated the 
presence of PRV vector since their electrophysiological properties were not 
fundamentally changed by the virus. The survival of the cells suitable for 
electrophysiological studies even after 4 days was high enough, proving that the virus 
entered the cells, did not cause any observable substantial cytotoxic effects; moreover 
the cells displayed unaltered electrophysiological properties. This was analyzed by 1) 
measuring the properties of a specific trans-membrane ionic current, the transient 
outward current (Ito), which is known to be ubiquitously present in all ventricular 
myocytes; 2) analyzing the intracellular Ca2+ transient by FRET. In these measurements 
we found that Ito was present in all cells even after 72 hours of viral infection, and 
neither the density nor the kinetics was different than that of observed in control cells 
(Fig 4). On the other hand we found that the kinetics of the intracellular Ca2+ transient 
was not significantly different between infected and non-infected cells (Fig 5, 6). 
Specifically, we found that infected adult dog myocytes had a lower rate of 
physiological degradation than that of the non-infected control cell culture in every 
parameter. One possible explanation for this unexpected result is that delayed apoptosis 
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was induced by the virus infection probably by inactivating the caspase system [40]. 
Recent studies have suggested that the latency-associated transcript (LAT) region of 
herpes simplex virus type 1 (HSV-1) is effective at blocking virus-induced apoptosis in 
vitro in various cell types [41, 42]. Alternatively, since anti-apoptotic effects depend on 
intracellular Ca2+ level [43], it is possible that Ca2+ level was decreased by binding a 
portion of Ca2+ to troponeon therefore the lower Ca2+ level inhibited cell death. 
However, the verification of this effect needs further investigation. 
 
Conclusions 
We have developed a PRV-based vector for delivery of genetically encoded 
activity sensors to cultured canine cardiomyocytes. This system has several 
advantageous features: the virus enters to cells without destroying the intact 
physiological properties of the cells it for a prolonged period; the virus does not change 
the measured physiological properties. We tested the survival rate, physiological 
changes on ionic current, contractile function and Ca2+ signalling under effect of virus 
mediated gene transfer in cultured adult canine cardiomyocytes. Our results show that 
novel herpesvirus-based vectors can transduce genes efficiently into non-dividing 
cardiac myocytes. Future studies are required to evaluate, whether PRV will be effective 
for in vivo infection for physiological research or gene therapeutic application. 
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 Figure legends 
Figure 1 This panel shows a part of recombinant herpes virus genome. To adapt for 
applicability as virus vector we deleted the two ribonucleotide reductase (rr) and the 
early protein (ep0) genes from the virus genome by homologue recombination The rr1 
and rr2 genes are in charge for production of raw material of viral DNA. The 
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recombinant virus is not able to productively infect post-mitotic cells without rr genes, 
while ep0 gene is responsible for virus reactivation from latency. Troponeon calcium 
sensor gene was inserted into the antisense promoter region in two copies. 
Figure 2 Representative low- and high magnification transillumination of adult dog 
myocytes after isolation (day 0) and 1-3 days of culture (day 1, day 3). Panel A shows 
the yield of the myocytes before and one day after culturing and infection. The high-
magnification transillumination (panel B) shows the morphology of adult dog myocytes 
after isolation (day 0) and 1-3 day of culture (day 1, day 3) and the morphological 
changes of living cells, versus the culturing time from non-infected (right) and the virus 
infected groups (left). After one day plated myocytes more than 80% displayed a rod-
shaped morphology and healthy cross-striation. After 3 days (day 3) in culture, cells 
remained rod-shaped and partially cross-striated, and the main change was that cell ends 
became progressively more rounded. 
Figure 3 Representative light (top) and fluorescent (bottom) microscopic images of cell 
culture, before and after 1 day and 3 days of virus infection. Expression of recombinant 
pseudorabies-viral troponeon transgenes appeared on high level in cultured adult dog 
ventricular myocytes. The isolation of adult dog left ventricular myocytes yielded more 
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than 80% living cells. After three days the troponeon expression and the physiological 
features of survival myocytes was appropriate for the physiological studies. 
Figure 4 Panel A. Transient outward K current (Ito) recordings from control and from 
virus infected myocytes after 1 (A) and 3 days (B) of culture. Inset shows applied 
voltage protocol. Panel B shows the Ito current densities from control and from virus 
infected myocytes after 1 to 4 days long culture. Data represent means ± SEM, and n 
represents the number of experiments. 
Figure 5 Original Ca2+ transients and cell contraction recording in cardiomyocytes 
cultured for 1 and 3 days. The top panel shows the intracellular Ca2+ concentration as 
Ca2+ transient fluorescent signal (F535nm), and bottom panel shows the changes in cell 
length. 
Figure 6. This figure shows several parameters of intracellular free calcium transient 
such as amplitude of calcium transients (A), diastolic calcium levels (B), changes of 
calcium transient decay constant (C) and cell-shortening measurements (D) from 
recordings from control and from virus infected myocytes after 1 to 3 days long culture. 
Bars represent means ± SEM, and n represents the number of experiments. 
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Figure 7 Panel A. Original recordings from cells expressed troponeon at the excitation 
wavelength of 485 and 535 nm (top) and the characterized calcium transient (B) by ratio 
of the fluorescence intensity (FCFP 485 / FCITRINE 535) from one day after infection. 
 
Figure legends 
Table 1 This table shows the survival of non-infected and virally infected cells from 
day 0 to day 5. It can be seen that virally infected cells exhibit slightly better survival 
than non-infected cells, for which the reason remains to be ascertained.  
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Figure 5
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Figure 6
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Table 1. 
 
  Day 0 Day 1 Day 2 Day 3 Day 4 Day 5 
Control Average (%): 100 60,0 44,9 4,3 2,8 2,2 
 Standard error:   6,0 8,4 0,5 0,3 0,3 
Virus 
infected Average (%): 100 85,5 69,2 12,8 3,1 1,3 
 Standard error:   4,7 9,3 3,7 1,5 0,6 
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